PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'UCL Institute of Health Informatics, UCL, London, UK; Public Health England, London, UK.\', \'UCL Institute of Health Informatics, UCL, London, UK.\', \'UCL Institute for Global Health, UCL, London, UK.\', \'Public Health England, London, UK.\', \'Department of Health and Social Care, London, UK.\', \'Palantir Technologies UK, London, UK.\', \'Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.\', \'UCL Institute of Epidemiology & Healthcare, UCL, London, UK; Health Data Research UK, London, UK.\', \'UCL Institute of Health Informatics, UCL, London, UK. Electronic address: l.shallcross@ucl.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1473-3099(21)00289-910.1016/S1473-3099(21)00289-9
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34174193
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34174193>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34174193>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all